Immunological alternation in COVID-19 patients with cancer and its implications on mortality

Patients with malignancy were reportedly more susceptible and vulnerable to Coronavirus Disease 2019 (COVID-19), and witnessed a greater mortality risk in COVID-19 infection than noncancerous patients. But the role of immune dysregulation of malignant patients on poor prognosis of COVID-19 has remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Guangyao, Gao, Yue, Zeng, Shaoqing, Yu, Yang, Liu, Xingyu, Liu, Dan, Wang, Ya, Yu, Ruidi, Desai, Aakash, Li, Chunrui, Gao, Qinglei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801126/
https://www.ncbi.nlm.nih.gov/pubmed/33489469
http://dx.doi.org/10.1080/2162402X.2020.1854424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801126/
https://www.ncbi.nlm.nih.gov/pubmed/33489469
http://dx.doi.org/10.1080/2162402X.2020.1854424

Ejemplares similares